Transcranial magnetic stimulation distinguishes Alzheimer disease from frontotemporal dementia

Conclusions: TMS is a noninvasive procedure that reliably distinguishes AD from FTD and HC and, if these findings are replicated in larger studies, could represent a useful additional diagnostic tool for clinical practice. Classification of evidence: This study provides Class III evidence that TMS measures can distinguish patients with AD from those with FTD.
Source: Neurology - Category: Neurology Authors: Tags: Diagnostic test assessment, Alzheimer's disease, TMS, Frontotemporal dementia, Assessment of cognitive disorders/dementia ARTICLE Source Type: research